Drug intelligence / Profile preview

3'-fluoro-3'-deoxythymidine 5'-monophosphate

Development stage
Discontinued
Lead developer
ForDoz Pharma
Modality
Small Molecules
01

Overview

**Description:**\n3′‑Fluoro‑3′‑deoxythymidine 5′‑monophosphate is a synthetic nucleotide analogue of thymidine monophosphate in which the hydroxyl group at the ribose’s third carbon is replaced by fluorine. It belongs to the class of pyrimidone nucleotides and acts as an inhibitor or substrate for certain kinases such as Mycobacterium tuberculosis thymidylate kinase. The compound has been studied primarily as a biochemical tool and experimental agent; it was investigated in early-stage clinical trials (up to phase II) for antiviral applications but development was discontinued[1][2][4][7]. It is not approved for any therapeutic use.

Other names
3'-Fluoro-3'-deoxythymidine 5'-monophosphate3'-Deoxy-3'-fluorothymidine monophosphate3-Fluoro-3-deoxythymidine monophosphate5'-Thymidylic acid, 3'-deoxy-3'-fluoro-[(2R,3S,5R)-3-fluoro-5-(5-methyl–2,4-dioxopyrimidin–1–yl)oxolan–2–yl]methyl dihydrogen phosphateCAS:25520‑83‑6
02

Targets

TMPK (Thymidine monophosphate kinase (Mycobacterium tuberculosis))

Beyond the preview

Go deeper on 3'-fluoro-3'-deoxythymidine 5'-monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3'-fluoro-3'-deoxythymidine 5'-monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call